Cite
HARVARD Citation
Guven, D. et al. (2022). The efficacy of immune checkpoint inhibitors in rare tumors: A systematic review of published clinical trials. Critical reviews in oncology/hematology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Guven, D. et al. (2022). The efficacy of immune checkpoint inhibitors in rare tumors: A systematic review of published clinical trials. Critical reviews in oncology/hematology. p. . [Online].